HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced anti-tumor efficacy of hyaluronic acid modified nanocomposites combined with sonochemotherapy against subcutaneous and metastatic breast tumors.

Abstract
Sonochemotherapy is a promising strategy for inhibiting tumor growth. However, achieving highly targeted and effective sonochemotherapy is still an enormous challenge. In this study, a novel chemotherapeutic-carrying nanocomposite (HPCID) was developed, which can effectively target metastatic cancer cells and provide an enhanced therapeutic effect. In detail, HPCID was composed of hyaluronic acid (HA), carboxyl-terminated PAMAM dendrimer, fluorochrome indocyanine green (ICG), and doxorubicin hydrochloride (Dox). The efficacy of this drug delivery system (DDS) in sonochemotherapy was assessed on the CD44-overexpressing metastatic breast cancer cell line 4T1 both in vitro and in vivo. The HA modification significantly improved the cellular internalization of HPCID, and the degradation of the HA shell by hyaluronidase that is abundant in the 4T1 cells resulted in enzyme-responsive drug release. Under ultrasound (US) stimulation, HPCID produced a high amount of reactive oxidant species (ROS), which induced significant cell apoptosis when combined with chemotherapy. In addition, the administration of HPCID in 4T1 xenograft-bearing mice combined with ultrasonic exposure significantly inhibited tumor growth and pulmonary metastasis, with no systemic toxicity. Taken together, the proposed HPCID-mediated sonodynamic therapy (SDT) is a novel strategy against breast cancer progression and metastasis.
AuthorsPengying Wu , Yue Sun , Wei Dong , Huige Zhou , Shifang Guo , Lei Zhang , Xiaobing Wang , Mingxi Wan , Yujin Zong
JournalNanoscale (Nanoscale) Vol. 11 Issue 24 Pg. 11470-11483 (Jun 20 2019) ISSN: 2040-3372 [Electronic] England
PMID31124554 (Publication Type: Journal Article, Retracted Publication)
Chemical References
  • Doxorubicin
  • Hyaluronic Acid
Topics
  • Animals
  • Doxorubicin (chemistry, pharmacology)
  • Drug Delivery Systems
  • Female
  • Hyaluronic Acid (chemistry, pharmacology)
  • Mammary Neoplasms, Experimental (metabolism, therapy)
  • Mice
  • Mice, Inbred BALB C
  • Nanocomposites (chemistry, therapeutic use)
  • Neoplasm Metastasis
  • Ultrasonic Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: